RxDoctor Payments Data

Adam Raschko

Physician Assistant · Indianapolis, INNPI 1710607163

Payments from drug & device makers

$372in general payments, 2019–2025

Across 15 payments — averaging $24.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$134
  • Medtronic$48
  • Amgen$40
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$38
  • Scpharmaceuticals Inc.$28
  • Kestra Medical Technology Services, Inc.$25
  • plus $59 from 3 others

What the payments were for

  • Food & beverage$372100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$372 in reported general payments places this provider in the 60th percentile of 1,955 physician assistant providers in Indiana.

See all physician assistant providers in Indiana

Medicare billing

Part B allowed, 2024
$36,788
Medicare patients
367
Services billed
527

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan92$77,230
EliquisApixaban55$66,398
JardianceEmpagliflozin69$57,236
Torsemide78$1,395
Metoprolol Succinate123$1,354
Spironolactone131$614
Diltiazem 24hr Er (Cd)Diltiazem Hcl20$531
Klor-Con M20Potassium Chloride30$411
Carvedilol53$356
Losartan Potassium58$315
Potassium Chloride29$314
Furosemide74$287
Atorvastatin Calcium39$265
Ezetimibe23$259
Isosorbide Mononitrate ErIsosorbide Mononitrate36$246

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$23$77,23092 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,955 physician assistant providers in Indiana.

Other physician assistant in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →